2 Firms Build $2.4B Sale Of SF Biopharmaceutical Biz
By Jade Martinez-Pogue · June 20, 2023, 1:54 PM EDT
Pharmaceutical giant Eli Lilly & Co. on Tuesday announced that it has agreed to purchase San Francisco-based biopharmaceutical company Dice Therapeutics in a deal totaling roughly $2.4 billion and built by...
To view the full article, register now.